Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group
C. J.A. Punt, S. Suciu, M. A. Gore, J. Koller, W. H.J. Kruit, J. Thomas, P. Patel, D. Lienard, A. M.M. Eggermont, U. Keilholz
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
15Citaten
(Scopus)
Vingerafdruk
Duik in de onderzoeksthema's van 'Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group'. Samen vormen ze een unieke vingerafdruk.